225 related articles for article (PubMed ID: 34697370)
1. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer.
Ruff SE; Vasilyev N; Nudler E; Logan SK; Garabedian MJ
Commun Biol; 2021 Oct; 4(1):1221. PubMed ID: 34697370
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK
Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
[TBL] [Abstract][Full Text] [Related]
4. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
5. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.
van der Poel HG; Zevenhoven J; Bergman AM
Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of androgen receptor-dependent transcription by the serine/threonine kinase Pim-1.
Thompson J; Peltola KJ; Koskinen PJ; Jänne OA; Palvimo JJ
Lab Invest; 2003 Sep; 83(9):1301-9. PubMed ID: 13679438
[TBL] [Abstract][Full Text] [Related]
8. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
[TBL] [Abstract][Full Text] [Related]
9. Androgen Receptor and
Ntzifa A; Strati A; Koliou GA; Zagouri F; Pectasides D; Pentheroudakis G; Christodoulou C; Gogas H; Magkou C; Petraki C; Kosmidis P; Aravantinos G; Kotoula V; Fountzilas G; Lianidou E
Cancer Genomics Proteomics; 2021; 18(2):147-156. PubMed ID: 33608311
[TBL] [Abstract][Full Text] [Related]
10. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
[TBL] [Abstract][Full Text] [Related]
12. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
Holder SL; Abdulkadir SA
Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
[TBL] [Abstract][Full Text] [Related]
13. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C
PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532
[TBL] [Abstract][Full Text] [Related]
14. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
Weber H; Ruoff R; Garabedian MJ
PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
[TBL] [Abstract][Full Text] [Related]
15. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition.
van der Meer R; Song HY; Park SH; Abdulkadir SA; Roh M
Clin Cancer Res; 2014 Jun; 20(12):3211-21. PubMed ID: 24771642
[TBL] [Abstract][Full Text] [Related]
16. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
[TBL] [Abstract][Full Text] [Related]
17. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.
Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A
PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217
[TBL] [Abstract][Full Text] [Related]
18. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract][Full Text] [Related]
19. PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.
Jensen CC; Clements AN; Liou H; Ball LE; Bethard JR; Langlais PR; Toth RK; Chauhan SS; Casillas AL; Daulat SR; Kraft AS; Cress AE; Miranti CK; Mouneimne G; Rogers GC; Warfel NA
J Cell Biol; 2023 Jun; 222(6):. PubMed ID: 37042842
[TBL] [Abstract][Full Text] [Related]
20. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]